USING CONTENT MARKETING TO GENERATE DEMAND, CREATE NEW AUDIENCES

August 14, 2019

Content—and how brands use it to interact with buyers at all stages of the engagement journey—has fundamentally reshaped every business’ go-to-market strategy. This shift has been particularly challenging for “top-of-the-funnel” demand generation marketers, most of who are under tremendous pressure to produce results. One study found that 70% of marketers surveyed expect their demand generation budgets to increase in 2018, with one-third expecting them to increase by more than 20%.1 Of course, generating demand is the job of marketing writ large. Marketers make markets. They work to create groups of viable buyers where none existed before.

Spotlight

DOHAPHARMA CO., LTD.

Dohapharma Co., Ltd. is market leader in pharmaceutical sector of Viet Nam, specialized in marketing and sales of pharmaceutical products. We are a dynamic marketing and trading company specialized in the importing and distribution of pharmaceutical and biologicals products in Vietnam. Currently we are importing and distributing a wide range of pharmaceutical products from world-class producers. If you are planning to address the Vietnamese market for your products, we have the answer for you. With a good sales and marketing infrastructure in the entire Vietnam republic as well as private sector of GPs and pharmacies through out the country, we could frontend you for your products. Dohapharma helps our clients to expand market share in the Vietnamese pharmaceutical market. Our team has extensive experience working in different fields of the pharmaceutical industry. We have experience from different levels including top management, business development, Rx and OTC marketing & sales, reg

OTHER WHITEPAPERS
news image

2020 Prescription Drug List

whitePaper | April 7, 2020

The information in this document is designed to help you understand the prescription drug benefits offered under this plan and to compare these benefits to those offered by other plans. Information contained in this summary is designed to help you compare both the value and scope offormulary benefits.

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More
news image

Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence

whitePaper | November 25, 2019

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.

Read More
news image

Protein fingerprints pave the way for microarray comparison

whitePaper | June 9, 2022

Anaxomics has developed a novel method of analysis for microarray data based on the generation and subsequent comparison of 2D fingerprints for each sample. Microarray results are incorporated into a protein interaction network and embedded with all sorts of biological and medical data.

Read More
news image

Pharma 2020: Marketing the future. Which path will you take?

whitePaper | August 8, 2021

If Pharma is to create a new marketing and sales model that is fit for 2020, it will have to begin by analysing its own value chain to identify opportunities for working more closely with healthcare payers and providers. It will, for example, have to collaborate much more closely with payers (be they governments, health insurers, employers or patients) to ensure that it develops medicines which have real social and economic value.

Read More
news image

Assessing drug target association from biological evidences

whitePaper | July 7, 2022

The full drug target profile identification is many times a necessary step in drug development process. Recently, the move to a more holistic approach in drug discovery has resulted in the increasing use of cell-based assays to discover new biologically active small molecules.

Read More

Spotlight

DOHAPHARMA CO., LTD.

Dohapharma Co., Ltd. is market leader in pharmaceutical sector of Viet Nam, specialized in marketing and sales of pharmaceutical products. We are a dynamic marketing and trading company specialized in the importing and distribution of pharmaceutical and biologicals products in Vietnam. Currently we are importing and distributing a wide range of pharmaceutical products from world-class producers. If you are planning to address the Vietnamese market for your products, we have the answer for you. With a good sales and marketing infrastructure in the entire Vietnam republic as well as private sector of GPs and pharmacies through out the country, we could frontend you for your products. Dohapharma helps our clients to expand market share in the Vietnamese pharmaceutical market. Our team has extensive experience working in different fields of the pharmaceutical industry. We have experience from different levels including top management, business development, Rx and OTC marketing & sales, reg

Events